Loss or reduction of Fhit expression in renal neoplasias: Correlation with histogenic class

Human Pathology

Volumn 30, Issue 11, 1999, Pages 1276-1283

  Hadaczek, Piotr ^b   Kovatich, A L ^b   Gronwald, Jacek ^b   Lubinski, Jan ^b   Huebner, Kay ^b   Mccue, Peter A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NONE

Author keywords

Chromosome 3p loss; Fhit protein expression; Renal neoplasia subtypes

Indexed keywords

ADULT; AGED; ALLELISM; ARTICLE; CANCER INVASION; CHROMOSOME 3; CHROMOSOME TRANSLOCATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY TUBULE EPITHELIUM; KIDNEY TUMOR; MALE;

EID: 0032741105     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90056-4     Document Type: Article

References (39)

1. Union Internationale Contre Le Cancer (UICC) and the American Joint Committee on Cancer (AJCC): Diagnosis and prognosis of renal cell carcinoma. Cancer 80:973-1001, 1997
2. Presti JC, Jr, Hoger M, Reuter VE, et al: Comparative genomic hybridization for genetic analysis of renal oncocytomas. Genes Chromosom Cancer 17:199-204, 1996
3. Kovacs G, Fuzesi L, Emanuel A, et al: Cytogenetics of papillary renal cell carcinomas. Genes Chromosom Cancer 3:249-255, 1991
4. Glukhova L, Goguel AF, Chudoba I, et al: Overrepresentation of 7q31 and 17q in renal cell carcinomas. Genes Chromosom Cancer 22:171-178, 1998
5. Amin MB, Corless CL, Renshaw AA, et al: Papillary (chromophil) renal cell carcinoma: Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 21:621-635, 1997
6. Hadaczek P, Podolski J, Toloczko A, et al: Accumulation of losses at 3p common deletion sites is characteristic of clear cell renal cell carcinoma. Virchows Arch 429:37-42, 1996
7. Shridhar V, Wang L, Rosati R, et al: Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas. Oncogene 14:1269-1277, 1997
8. Schmidt L, Duh FM, Chen F, et al: Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nat Genet 16:68-73, 1997
9. Akhtar M, Kardar H, Linjawi T, et al: Chromophobe cell carcinomas of the kidney: A clinicopathologic study of 21 cases. Am J Surg Pathol 19:1245-1256, 1995
10. Crotty TB, Farrow GM, Lieber MM: Chromophobe cell renal carcinoma: Clinicopathological features of 50 cases. J Urol 154:964-967, 1995
11. Renshaw AA, Henske EP, Loughlin KR, et al: Aggressive variants of chromophobe renal cell carcinoma. Cancer 78:1756-1761, 1996
12. Speicher M, Schoell B, du Manoir S, et al: Loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 145:356-364, 1994
13. Bugert P, Gaul C, Weber K, et al: Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest 76:203-208, 1997
14. Kovacs H, Kovacs G: Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosom Cancer 4:267-268, 1992
15. Huebner K, Garrison PN, Barnes LD, et al: The role of the FRA3B/FHIT locus in cancer. Annu Rev Genet 32:7-31, 1998
16. Kaelin WG, Jr, Maher ER: The VHL tumor-suppressor gene paradigm. TIG 14:423-426, 1998
17. Clifford SC, Prowse AH, Affara NA, et al: Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL-independent pathway in clear cell renal tumourigenesis. Genes Chromosom Cancer 22:200-209, 1998
18. Oda H, Nakatsuru Y, Ishikawa T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res 55:658-662, 1995
19. Fuzezi L, Cober M, Mittermayer C: Collecting duct carcinoma: Cytogenetic characterization. Histopathology 21:155-160, 1992
20. Bugert P, Kovacs G: Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol 149:2081-2088, 1996
21. Moch H, Presti JC Jr, Sauter G, et al: Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56:27-30, 1996
22. Bugert P, Wilhelm M, Kovacs G: FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Genes Chromosom Cancer 20:9-15, 1997
23. van den Berg A, Draaijers TG, Kok K, et al: Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region. Genes Chromosom Cancer 19:220-227, 1997
24. Lubinski J, Hadaczek P, Podolski J, et al: Common regions of deletion in chromosome regions 3p12 and 3p14.2 in primary clear cell renal carcinomas. Cancer Res 54:3710-3713, 1994
25. Druck T, Kastury K, Hadaczek P, et al: Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Cancer Res 55:5348-5353, 1995
26. Fuhrman S, Lasky L, Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655-663, 1982
27. Fromowitz FB, Bard RH: Clinical implication of pathologic subtypes in renal cell carcinoma. Semin Urol 8:31-50, 1990
28. Robson CJ, Churchill BM, Anderson W: The results of radical nephrectomy for renal cell carcinomas. J Urol 101:297-301, 1969
29. Hadaczek P, Siprashvili Z, Markiewski M, et al: Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res 58:2946-2951, 1998
30. Kovatich A, Friedland DM, Druck T, et al: Human chromosome 3p alterations in neuroendocrine lung tumors. Cancer 83:1109-1117, 1998
31. Druck T, Hadaczek P, Fu T-B, et al: Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 57:504-512, 1997
32. Siprashvili Z, Sozzi G, Barnes LD, et al: Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A 94:13771-13776, 1997
33. Greenspan DL, Connolly DC, Wu R, et al: Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 57:4692-4698, 1997
34. Xiao G-H, Jin F, Klein-Szanto AJP, et al: The FHIT gene product is highly expressed in the cytoplasm of renal tubular epithelium and is down-regulated in kidney cancers. Am J Pathol 151:1541-1547, 1997
35. Moch H, Schraml P, Bubendorf L, et al: Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization. Cancer Res 58:2304-2309, 1998
36. Lott ST, Lovell M, Naylor S, et al: Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12. Cancer Res 58:3533-3537, 1998
37. Wilhelm M, Bugert P, Kenck C, et al: Terminal deletion of chromosome 3p sequences in nonpapillary renal cell carcinomas: A breakpoint cluster between loci D3S1285 and D3S1603. Cancer Res 55:5383-5385, 1995
38. Van den Berg A, Hulsbeek MME, de Jong D, et al: Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chromosom Cancer 15:64-72, 1996
39. Tanaka H, Shimada Y, Harada H, et al: Methylation of the 5′ CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res 58:3429-3434, 1998